ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
Recruiting · NCT05629702 · Registry updated 2026-05-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids | Brain Tumor, Recurrent, Chemically-Induced Disorders, Disease Attributes, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, astrocytoma (excluding glioblastoma), brain disorder, cannabis dependence, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioblastoma, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor, psychiatric disorder, substance-related disorder | Recruiting | Phase 2 | 2026-05-05 | NCT05629702 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jazz Pharmaceuticals | 60 |
| The Brain Tumour Charity | 2 |
| University of Birmingham | 75 |
| University of Leeds | 70 |
22 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.